BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21830375)

  • 21. Molecular analysis of the fragile histidine triad (FHIT) tumor suppressor gene in vesical tumors of cattle with chronic enzootic hematuria (CEH).
    Guidi E; Uboldi C; Ferretti L
    Cytogenet Genome Res; 2008; 120(1-2):173-7. PubMed ID: 18467844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
    Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
    Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of fragile histidine triad gene on biologic properties of muco-epidermoid carcinoma cells.
    Liu F; Wu JZ; Li F; Li Y; Li J
    Cytotherapy; 2008; 10(7):753-8. PubMed ID: 18985481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fhit Nuclear Import Following EGF Stimulation Sustains Proliferation of Breast Cancer Cells.
    Bianchi F; Sasso M; Turdo F; Beretta GL; Casalini P; Ghirelli C; Sfondrini L; Ménard S; Tagliabue E; Campiglio M
    J Cell Physiol; 2015 Nov; 230(11):2661-70. PubMed ID: 25711523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular mechanism of γ-aminobutyric acid inhibitory on the growth of cholangiocarcinoma QBC939 cell line].
    Zhu CL; Huang Q; Liu CH; Xie F; Zhu K
    Zhonghua Wai Ke Za Zhi; 2013 Mar; 51(3):261-5. PubMed ID: 23859331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
    Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisense RhoC gene suppresses proliferation and invasion capacity of human QBC939 cholangiocarcinoma cells.
    Shi Z; Chen ML; He QL; Zeng JH
    Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):516-20. PubMed ID: 17897917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implication of mitochondrial involvement in apoptotic activity of fragile histidine triad gene: application of synchronous luminescence spectroscopy.
    Askari MD; Vo-Dinh T
    Biopolymers; 2004 Mar; 73(4):510-23. PubMed ID: 14991669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased FHIT protein expression correlates with a worse prognosis in patients with diffuse large B-cell lymphoma.
    Chen PM; Yang MH; Hsiao LT; Yu IT; Chu CJ; Chao TC; Yen CC; Wang WS; Chiou TJ; Liu JH
    Oncol Rep; 2004 Feb; 11(2):349-56. PubMed ID: 14719066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteration of the fragile histidine triad gene in intrahepatic cholangiocarcinoma.
    Koch E; Fiedler W; Tannapfel A; Ballhausen WG
    Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):907-13. PubMed ID: 12867802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological functions of mammalian Nit1, the counterpart of the invertebrate NitFhit Rosetta stone protein, a possible tumor suppressor.
    Semba S; Han SY; Qin HR; McCorkell KA; Iliopoulos D; Pekarsky Y; Druck T; Trapasso F; Croce CM; Huebner K
    J Biol Chem; 2006 Sep; 281(38):28244-53. PubMed ID: 16864578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fragile histidine triad expression in rhabdomyosarcoma].
    Wang SL; Yang GH; Bu H; Guo LX; Zhou Q; Zhang HY; Ye L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):176-8. PubMed ID: 15071908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development.
    Lea JS; Ashfaq R; Muneer S; Burbee DG; Miller DS; Minna JD; Muller CY
    J Soc Gynecol Investig; 2004 Jul; 11(5):329-37. PubMed ID: 15219888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent altered expression of fragile histidine triad protein in human colorectal adenomas.
    Morikawa H; Nakagawa Y; Hashimoto K; Niki M; Egashira Y; Hirata I; Katsu K; Akao Y
    Biochem Biophys Res Commun; 2000 Nov; 278(1):205-10. PubMed ID: 11071873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
    Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
    Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppression.
    Semba S; Huebner K
    Mol Cancer Res; 2006 Aug; 4(8):529-38. PubMed ID: 16885564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. microRNA-143 protects cells from DNA damage-induced killing by downregulating FHIT expression.
    Lin YX; Yu F; Gao N; Sheng JP; Qiu JZ; Hu BC
    Cancer Biother Radiopharm; 2011 Jun; 26(3):365-72. PubMed ID: 21711110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Fragile Histidine Triad gene and breast cancer.
    Yang Q; Yoshimura G; Sakurai T; Kakudo K
    Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma.
    Tzao C; Sun GH; Tung HJ; Hsu HS; Hsu WH; Wang YC; Cheng YL; Lee SC
    Ann Thorac Surg; 2006 Aug; 82(2):396-401; discussion 401. PubMed ID: 16863736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.